Effects of Variable Ventilation on Respiratory System of Acute Respiratory Distress Syndrome (ARDS) Patients
1 other identifier
interventional
16
1 country
1
Brief Summary
The purpose of this study is to determine the effects of variable ventilation on respiratory system of patients affected by acute respiratory distress syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2005
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 12, 2005
CompletedFirst Posted
Study publicly available on registry
September 20, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2015
CompletedMarch 19, 2015
March 1, 2015
8 years
September 12, 2005
March 18, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gas exchange and respiratory mechanics
within the first 60 minutes from the ventilatory change
Study Arms (1)
1
EXPERIMENTALALI/ARDS patients
Interventions
Patients will be mechanically ventilated with Variable Ventilation (3 step with increased level of variability) and "traditional" CMV, for a total of 4 step. Each step lasts in 60 minutes. During this period the investigators will record the gas exchange parameters and the mechanics of the respiratory system.
Eligibility Criteria
You may qualify if:
- Patients with ARDS criteria
You may not qualify if:
- Age less than 18 years
- Severe haemodynamic instability
- Patients with clinical or instrumental evidence of flow-limitation (i.e., PEEPi)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Policlinico Hospital
Milan, Italy
Study Officials
- PRINCIPAL INVESTIGATOR
Paolo Taccone, MD
Policlinico Hospital Milan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
September 12, 2005
First Posted
September 20, 2005
Study Start
March 1, 2005
Primary Completion
March 1, 2013
Study Completion
March 1, 2015
Last Updated
March 19, 2015
Record last verified: 2015-03